64 research outputs found
sj-docx-1-msc-10.1177_09691413221090892 - Supplemental material for COVID-19 disruption to cervical cancer screening in England
No full textSupplemental material, sj-docx-1-msc-10.1177_09691413221090892 for COVID-19 disruption to cervical cancer screening in England by Alejandra Castanon, Matejka Rebolj, Francesca Pesola, Philippa Pearmain and Ruth Stubbs in Journal of Medical Screening</p
How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
No full textR Wuntakal, A Castanon are joint first authors.
© 2015 Wuntakal et al. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2393/15/232This manuscript presents independent research funded by the National
Institute for Health Research (NIHR) under its Research for Patient Benefit
(RfPB) Programme (Grant Reference Number PB-PG-1208-16187). The views
expressed are those of the author(s) and not necessarily those of the NHS,
the NIHR or the Department of Health. The funder had no input in the
design, conduct, collation, analysis or interpretation of the data or the
preparation, review or approval of the manuscript
Cone depth increases risk of adverse obstetric outcomes following treatment for cervical preinvasive disease.
No full text[Company Message] from [Al G.] Hemming to Peggy, [Carson Estate Company], 1947
No full textInternal message taken from Al G. Hemming requesting two lease agreements for lease on Lot 14, Tract 4054 for C. Castanon beginning September 1, 1947, ending September 1, 1948 and Lease No. 9 for Sunru Chang, beginning July 1, 1947, ending June 30, 1948 with an increase in cost
Report on the Field Trip to Mexico
No full textMexico, name of a "project" open to the future rather than a country or a state (Adolfo Castanon) -. The following text is the brief report of interviews on the "trans-cultural Mexicanity," which were held with Mexican writers, critics and researchers in August 2002 in Mexico City. This report will be integrated into the book (in preparation) on the theme of Trans-Culture, Surrealism and Primitive Art
Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?
No full textThe rates of cervical cancer (CxCa) in England among women aged 20-24yrs increased from 2.7 in 2012 to 4.6 per 100,000 in 2014 (p=0.0006). There was concern that the sudden increase was linked to the withdrawal of cervical screening in women aged 20-24 (a policy that affected women born since 1984). We analyse granular data on age and FIGO stage at diagnosis using a generalised linear model to see whether the unprecedented increase in CxCa in young women in 2014 was linked to the change in 2012 to the age at which the first invitation to screening was sent (from 25.0 to 24.5). Annual rates of CxCa per 100,000 women aged 20.0-24.5yrs decreased gradually over time, whereas at age 24.5-25.0yrs they increased from an average of 16 pre-2013 to 49 in 2015. An increase of 20.3 per 100,000 women aged 24.5-25.0yrs (95% CI: 15.2-25.4) was associated with inviting women for screening at age 24.5yrs instead of at age 25.0. At age 25.0-25.5yrs, rates decreased by 23.7 per 100,000 after women were invited at age 24.5yrs (p<0.001). All these changes were limited to stage I CxCa. There was a dramatic increase in diagnoses at age 25yrs in 2009-2011 associated with changing the age at first invitation from 20yrs to 25yrs. No changes were observed at age 26.0-27.0yrs. The increase in CxCa aged 20-24 is attributable to an increase in the proportion of women first screened aged 24.5yrs. The increase was limited to stage I CxCa. There is no evidence of a lack of screening leading to increasing rates.Cancer Research UK [grant number
C8162/A16872
"Estudio y edicion critica de ""Sangre, valor y fortuna"", de Francisco Bances Candamo"
No full textSangre, valor y fortuna is the only play by dramatist Francisco Bances Candamo (1662-1704) which has never been published. It was not included in the Poesias comicas, the most complete collection of comedias by Bances Candamo, nor was it published in the form of a suelta, as happened with other plays by the same author. The only extant source for this comedia is one single manuscript kept as the Biblioteca Nacional, in Madrid. Its handwriting is seventeenth century, yet is is not the playwright's own.In addition to providing an extensive introduction that gives a useful biographical profile of Bances Candamo, as well as the historical background, I explore some of the most noteworthy aspects of the play, I offer my own edition of the text of Sangre, valor y fortuna, which is the first modern attempt to edit the manuscript and correct the copist's errors, thus presenting the play as close as possible to Bances Candamo's original intentions. Completing the edition is the critical apparatus, consisting of thorough explanatory footnotes and a bibliography--the most extensive about Bances Candamo up to date.Made available in DSpace on 2011-05-07T14:17:26Z (GMT). No. of bitstreams: 2
license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5)
9236465.pdf: 8740539 bytes, checksum: e78e8e8dc1b446d5ac0fa22f1aa2486f (MD5)
Previous issue date: 1992Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding ([email protected]) on 2011-05-07T15:05:04Z
Item is restricted indefinitely.Restriction data tranferred 2014-07-01T11:31:08-05:00
Original Data
Group with Access UIUC Users [automated]
Release Date: none
Reason: ETDs are only available to UIUC Users without author permissionETDs are only available to UIUC Users without author permissionU of I Onl
Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
No full textAge at which women are first invited to attend cervical screening in England has changed twice: in 2004, women under 25 years were no longer invited; and in 2012, first invitations were sent six months earlier (at age 24.5 years). Concomitantly, a dramatic increase in screen-detected cervical cancer was observed, and their survival had not been documented. Diagnoses of invasive cervical cancer at ages 20–29 years in 2006–2016 in England were followed until the end of 2018 for deaths. We estimated 8-year overall survival (OS) by International Federation of Gynecology and Obstetrics (FIGO) stage and age at first screening invitation. Overall and relative survival for stage IA cervical cancer for women diagnosed aged 20–29 years in England (n = 1905) was excellent at 99.8% (95% confidence intervals (CI): 99.4–99.9%) and 100% (95% CI: 99.7–100.1%), respectively. OS for stage IB cervical cancer (n = 1101) was 90.4% (95% CI: 88.3–92.2%). Survival from stage IB was worse for women diagnosed age 20–24 years compared to those diagnosed 25–29 years at diagnosis (p < 0.0001), but no difference was observed by age at first invitation for screening, p = 0.8575. OS for stage II (65.5%, 95% CI: 60.2–72.0%) and stage III+ (36.6%, 95% CI 28.4–44.7%) were poorer. Survival from stage I cervical cancer in young women in England is excellent: mortality in women with stage IA cancer is akin to that of the general population regardless of age at first invitation to screening
How many cervical cancers are prevented by treatment of screen‐detected disease in young women?
No full text- …
